Ivo G. Schoots
The Netherlands Cancer Institute, Erasmus MC, Erasmus University Rotterdam
Papers
12
Total Citations
349
H-Index
9
About
Dr. Ivo G. Schoots is a leading researcher in urologic oncology, whose work centers on improving the precision of prostate cancer diagnosis, staging, and treatment outcomes. His primary contributions lie in developing and validating novel predictive nomograms that integrate advanced imaging, such as prostate-specific membrane antigen (PSMA) PET and multiparametric MRI, to more accurately forecast pelvic lymph-node metastases and extraprostatic extension. These tools, externally validated in international multicenter studies with citations reaching 71, are directly shaping clinical decision-making for radical prostatectomy. Beyond staging, Dr. Schoots has made significant strides in functional outcomes, notably through quantitative assessments of membranous urethral length and fascia preservation to predict post-surgical continence and erectile function. His systematic review on focal ablative therapy (52 citations) critically evaluated the evidence landscape, offering clear recommendations for practice. By bridging the gap between cutting-edge imaging and patient-centered outcomes, Dr. Schoots’ work—encompassing over 300 citations from his top papers alone—provides clinicians with actionable, evidence-based tools to personalize prostate cancer management and improve quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10